Oxygenated albumin for use as blood and blood extender
2 The compositions described herein comprise oxygenated albumin in an aqueous sterile physiological or serum solution. The albumin is oxygenated to increase the oxygen content up to Osaturation with clinically useful oxygen gas. The preferred oxygen-saturated preparations, containing albumin in conc...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Ecanow, Bernard V |
description | 2 The compositions described herein comprise oxygenated albumin in an aqueous sterile physiological or serum solution. The albumin is oxygenated to increase the oxygen content up to Osaturation with clinically useful oxygen gas. The preferred oxygen-saturated preparations, containing albumin in concentrations from about 5% w/v to about 25% w/v, are useful as clinical resuscitation preparations that release oxygen in a pattern similar to the release of oxygen by whole blood. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07229967</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07229967</sourcerecordid><originalsourceid>FETCH-uspatents_grants_072299673</originalsourceid><addsrcrecordid>eNrjZDDzr6hMT81LLElNUUjMSSrNzcxTSMsvUigtTlVILFZIysnPB0rkpUBZqRUlqXkpqUU8DKxpiTnFqbxQmptBwc01xNlDt7S4AGhWXklxfHpRIogyMDcysrQ0MzcmQgkAUJcuOQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Oxygenated albumin for use as blood and blood extender</title><source>USPTO Issued Patents</source><creator>Ecanow, Bernard V</creator><creatorcontrib>Ecanow, Bernard V ; Hunter Research Corporation</creatorcontrib><description>2 The compositions described herein comprise oxygenated albumin in an aqueous sterile physiological or serum solution. The albumin is oxygenated to increase the oxygen content up to Osaturation with clinically useful oxygen gas. The preferred oxygen-saturated preparations, containing albumin in concentrations from about 5% w/v to about 25% w/v, are useful as clinical resuscitation preparations that release oxygen in a pattern similar to the release of oxygen by whole blood.</description><language>eng</language><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7229967$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7229967$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ecanow, Bernard V</creatorcontrib><creatorcontrib>Hunter Research Corporation</creatorcontrib><title>Oxygenated albumin for use as blood and blood extender</title><description>2 The compositions described herein comprise oxygenated albumin in an aqueous sterile physiological or serum solution. The albumin is oxygenated to increase the oxygen content up to Osaturation with clinically useful oxygen gas. The preferred oxygen-saturated preparations, containing albumin in concentrations from about 5% w/v to about 25% w/v, are useful as clinical resuscitation preparations that release oxygen in a pattern similar to the release of oxygen by whole blood.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDDzr6hMT81LLElNUUjMSSrNzcxTSMsvUigtTlVILFZIysnPB0rkpUBZqRUlqXkpqUU8DKxpiTnFqbxQmptBwc01xNlDt7S4AGhWXklxfHpRIogyMDcysrQ0MzcmQgkAUJcuOQ</recordid><startdate>20070612</startdate><enddate>20070612</enddate><creator>Ecanow, Bernard V</creator><scope>EFH</scope></search><sort><creationdate>20070612</creationdate><title>Oxygenated albumin for use as blood and blood extender</title><author>Ecanow, Bernard V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_072299673</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ecanow, Bernard V</creatorcontrib><creatorcontrib>Hunter Research Corporation</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ecanow, Bernard V</au><aucorp>Hunter Research Corporation</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Oxygenated albumin for use as blood and blood extender</title><date>2007-06-12</date><risdate>2007</risdate><abstract>2 The compositions described herein comprise oxygenated albumin in an aqueous sterile physiological or serum solution. The albumin is oxygenated to increase the oxygen content up to Osaturation with clinically useful oxygen gas. The preferred oxygen-saturated preparations, containing albumin in concentrations from about 5% w/v to about 25% w/v, are useful as clinical resuscitation preparations that release oxygen in a pattern similar to the release of oxygen by whole blood.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_07229967 |
source | USPTO Issued Patents |
title | Oxygenated albumin for use as blood and blood extender |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A51%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ecanow,%20Bernard%20V&rft.aucorp=Hunter%20Research%20Corporation&rft.date=2007-06-12&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07229967%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |